找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Kidney Cancer; Principles and Pract Primo N. Lara,Eric Jonasch Book 2015Latest edition The Editor(s) (if applicable) and The Author(s), und

[復制鏈接]
樓主: JAR
41#
發(fā)表于 2025-3-28 16:17:16 | 只看該作者
42#
發(fā)表于 2025-3-28 19:57:55 | 只看該作者
43#
發(fā)表于 2025-3-28 23:48:55 | 只看該作者
Biomarkers for Renal Cell Carcinomaf cancer. In contrast, biomarkers are helpful as more objective and reliable factors, which can either supplement or replace these largely subjective measures. Biomarkers can potentially play important roles in clinical research by clarifying measurable endpoints, which may lead to significant decre
44#
發(fā)表于 2025-3-29 06:58:02 | 只看該作者
45#
發(fā)表于 2025-3-29 10:28:56 | 只看該作者
46#
發(fā)表于 2025-3-29 14:46:21 | 只看該作者
47#
發(fā)表于 2025-3-29 19:03:27 | 只看該作者
Cytoreductive Nephrectomyry. This chapter will highlight the historical evolution of CN in the treatment of metastatic RCC, review the data regarding optimal patient selection, highlight the risks of CN, and explore future methods on how to better integrate surgery into the treatment of patients with metastatic RCC.
48#
發(fā)表于 2025-3-29 21:39:56 | 只看該作者
49#
發(fā)表于 2025-3-30 01:24:28 | 只看該作者
The Role of Radiation Therapy in Renal Cell Carcinomatment of RCC and conclude that RT does not have a major role in the management of localized RCC in the adjuvant setting but is effective for palliation and local control of distant sites of metastasis to the bone and brain in particular.
50#
發(fā)表于 2025-3-30 06:01:53 | 只看該作者
Adjuvant Systemic Therapy for Renal Cell Carcinomand have changed management of this stage of the disease. Many of these agents are currently being investigated in placebo-controlled adjuvant studies. While results of most of these trials are still awaited, there is optimism that these agents may prove effective and change the paradigm for the trea
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-9 04:58
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
兴仁县| 吴川市| 琼结县| 洛川县| 洞口县| 安陆市| 杭锦后旗| 石棉县| 南昌市| 余江县| 乌兰察布市| 临西县| 镇原县| 姚安县| 浦东新区| 新疆| 蓬莱市| 新沂市| 四川省| 宣武区| 中山市| 屏东县| 即墨市| 玛曲县| 巢湖市| 丁青县| 河北省| 杨浦区| 泽库县| 探索| 伊通| 武强县| 慈利县| 中卫市| 元江| 大安市| 苍溪县| 瓮安县| 玛纳斯县| 浮梁县| 龙南县|